Article
31 Oct 2025
New Drug Approvals: "Human Organ-on-a-Chip" GAO Report Supports Innovation And Regulatory Policy For Non-Animal Models
AUTHORS CONTENT
Article
21 Jul 2025
Navigating FDA's Proposed Guidance On AI And Non-Animal Models: Safeguarding Innovation In Drug Development
Article
25 Feb 2025
Clarifying The Copyrightability Of AI-Assisted Works
Article
20 Jan 2025
AI Drug Development: FDA Releases Draft Guidance
Article
26 Dec 2024
AI In Drug Discovery: 2025 Outlook
Article
19 Dec 2024
Protecting IP In A Cyber-Threatened World: Insights From Zifino And Foley & Lardner
Article
07 Oct 2024
I Build Generative AI Technology: Does California's New Transparency Requirement Apply To Me?
Article
15 Aug 2024
Technology Trends In Manufacturing And Associated Legal Risk Management: Driving Technological Advancement With An Ecosystem View
Article
17 Jul 2024
Patenting Power Plays For AI Drug Discovery
Article
12 Apr 2024
The Future Of Money With Zebec Network
Article
11 Mar 2024
Innovation In Biotech And AI (Video)
Article
07 Mar 2024
Leveraging Risk Management Frameworks For AI Solutions In Health Care
Article
05 Feb 2024
When Will The LLM Patent Wave Hit?
Article
18 Oct 2023
Keys To AI IP Strategy: A Comprehensive Framework
Article
24 Jul 2023
Building A Better AI Legal Framework: The EU AI Act And Beyond
Article
09 Jun 2023
Risks And Rewards For AI-Created Likenesses In Entertainment
Article
19 May 2023
The Role Of AI In Health Care M&A: Driving Value In A Difficult Market
Article
06 Apr 2023
Structuring IP Licenses To Manage Supply Chain Risks In The Automotive Industry
Article
06 Mar 2023
What's The Standard? Strategies For Protecting Standard Essential Patents
Article
09 Feb 2023
Private Investment Diligence And Fraud Prevention: Will New Regulations Change The Game?